Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

40.79 +2.75 (+7.23%)

Streaming Delayed Price Updated: 1:59 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses ↗

November 14, 2025

Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.

Via Benzinga

Twist Bioscience Corp (NASDAQ:TWST) Stock Falls After Q4 Earnings Miss ↗

November 14, 2025

Twist Bioscience Q4 2025 earnings miss analyst estimates on revenue and EPS, triggering a sharp pre-market stock decline.

Via Chartmill

Topics Earnings

Earnings Scheduled For November 14, 2025 ↗

November 14, 2025

Via Benzinga

Earnings Scheduled For August 4, 2025 ↗

August 04, 2025

Via Benzinga

Preview: Twist Bioscience's Earnings ↗

August 01, 2025

Via Benzinga

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

What's Next: Twist Bioscience's Earnings Preview ↗

May 02, 2025

Via Benzinga

Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings ↗

November 14, 2025

Via Benzinga

Earnings Outlook For Twist Bioscience ↗

November 13, 2025

Via Benzinga

This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

November 04, 2025

Via Benzinga

WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗

October 20, 2025

Via Benzinga

Topics Artificial Intelligence

Forecasting The Future: 6 Analyst Projections For Twist Bioscience ↗

February 04, 2025

Via Benzinga

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗

October 15, 2025

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.

Via Benzinga

Topics Artificial Intelligence

Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results ↗

August 05, 2025

Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.

Via Benzinga

Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings ↗

August 04, 2025

Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA breakeven fiscal 2026.

Via Benzinga

Twist Bioscience (TWST) Q3 Profit Surges ↗

August 04, 2025

Via The Motley Fool

Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat ↗

August 04, 2025

Twist Bioscience reported mixed Q3 2025 results, missing revenue estimates at $96.06M but beating EPS at -$0.47. Shares fell 5% pre-market as investors focused on the sales shortfall.

Via Chartmill

Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies ↗

June 27, 2025

Cathie Wood-led Ark Invest made notable trades on Friday, including selling shares in Coinbase and Roblox.

Via Benzinga

Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit ↗

May 26, 2025

Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.

Via Benzinga

Topics Artificial Intelligence

Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots ↗

May 12, 2025

Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.

Via Benzinga

Topics Artificial Intelligence

Where Twist Bioscience Stands With Analysts ↗

May 06, 2025

Via Benzinga

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday ↗

May 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 02, 2025

Via Benzinga

Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday ↗

March 01, 2025

Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS.

Via Benzinga

Topics Artificial Intelligence

Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday ↗

February 15, 2025

Cathie Wood-led Ark Invest made trades involving IRDM, TWST, PD, BEAM, ROKU, and IBTA.

Via Benzinga

Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs ↗

February 10, 2025

On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company.

Via Benzinga

Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday ↗

February 08, 2025

Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.

Via Benzinga

Earnings Scheduled For February 3, 2025 ↗

February 03, 2025

Via Benzinga

Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments ↗

November 29, 2024

Cathie Wood, founder and CEO of ARK Investment Management LLC, defended the future of artificial intelligence investments while highlighting Tesla Inc. as a cornerstone of technological innovation...

Via Benzinga

Topics Artificial Intelligence

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared? ↗

November 26, 2024

Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.